Results for tag: "Pouchitis Drug"

Pouchitis is an inflammation of the ileal pouch, a surgically created reservoir that replaces the large intestine in patients with ulcerative colitis. Treatment of pouchitis is typically with antibiotics, such as metronidazole, ciprofloxacin, and rifaximin. Other medications, such as probiotics, immunosuppressants, and biologics, may also be used. The pouchitis drug market is a subset of the larger gastrointestinal drug market. It is composed of pharmaceuticals used to treat pouchitis, as well as other drugs used to treat other gastrointestinal conditions. The market is driven by the increasing prevalence of gastrointestinal diseases, such as ulcerative colitis, and the need for effective treatments. Some companies in the pouchitis drug market include AbbVie, Allergan, AstraZeneca, Janssen, Merck, Pfizer, and Takeda. Show Less Read more